Revenue by source
Oncology$683.60MBiopharma & Data$210.13MScreening$79.73MLicensing & Other$8.56M
| Segment | 2025 |
|---|
| Oncology | $683.60M |
| Biopharma & Data | $210.13M |
| Screening | $79.73M |
| Licensing & Other | $8.56M |
Revenue by country
UNITED STATES$923.28MNon-US$58.74M
| Segment | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $77.92M | $194.31M | $264.66M | $352.56M | $420.62M | $526.52M | $697.16M | $923.28M |
| Non-US | $12.72M | $20.06M | $22.07M | $21.09M | $28.92M | $37.42M | $41.85M | $58.74M |